|Articles|April 11, 2022
Komodo Health and Datavant Expand Partnership
Collaboration reinforces value of connecting proprietary and third-party data.
Advertisement
Komodo Health and Datavant announced an expansion of their partnership. Together, they will enable life sciences companies to securely connect proprietary and third-party clinical trial data, specialty pharmacy data, and more to Komodo’s technology and insights platform.
Read more about the partnership expansion
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
What Impact will DTC Programs have on Generic Drug Prices?
3
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
4
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
5
